C-reactive protein impairs human CD14+ monocyte-derived dendritic cell differentiation, maturation and function

European Journal of Immunology

Volumn 36, Issue 11, 2006, Pages 2993-3006

  Zhang, Rongxin ^a   Becnel, Lauren ^a   Li, Min ^a   Chen, Changyi ^a   Yao, Qizhi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CRP; DC differentiation and activation; Endocytosis; Fc receptors; MLR

Indexed keywords

B7 ANTIGEN; C REACTIVE PROTEIN; CD14 ANTIGEN; CD209 ANTIGEN; CD32 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOMODULATION; IN VITRO STUDY; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD14; C-REACTIVE PROTEIN; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; DOWN-REGULATION; ENDOCYTOSIS; HUMANS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MONOCYTES; RECEPTORS, CELL SURFACE; RECEPTORS, IGG;

EID: 33751252803     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200635207     Document Type: Article

References (54)

1. Shrive, A. K., Holden, D., Myles, D. A. and Greenhough, T. J., Structure solution of C-reactive proteins: molecular replacement with a twist. Acta Crystallogr. D. Biol. Crystallogr. 1996. 52: 1049-1057.
2. Thompson, D., Pepys, M. B. and Wood, S. P., The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure Fold Des. 1999. 7: 169-177.
3. Oliveira, E. B., Gotschlich, C. and Liu, T. Y., Primary structure of human C-reactive protein. J. BioL Chem 1979. 254: 489-502.
4. Du Clos, T. W. and Mold C., C-reactive protein: structure, synthesis and function.In Wong, S. Y. and Arsequell, G. (Eds.) Immunobiology of Carbohydrates. Eurekah.com 1 Kluwer Academic/Plenum 2003, pp 39-54.
5. Nakahara, C., Kanemoto, K., Saito, N., Oyake, Y., Kamoda, T., Nagata, M. and Matsui, A., C-reactive protein frequently localizes in the kidney in glomerular diseases. Clin. Nephrol. 2001. 55: 365-370.
6. Baidoshvili, A., Nijmeijer, R., Lagrand, W. K., Hack, C. E. and Niessen, H. W., Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis. J. Clin. Pathol. 2002. 55: 152-153.
7. Do Cos. T. W., Function of C-reactive protein. Ann. Med. 2000. 32:274-278.
8. Heuertz, R. M., Piquette, C. A. and Webster, R.O., Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am J. Pathol. 1993. 142: 319-328.
9. Volanakis, J. E., Complement activation by C-reactive protein complexes. Ann. NY Acad. Sci. 1982. 389: 235-250.
10. Mold, C., Rodriguez, W., Rodic-Polic, B. and Du Clos, T. W., C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R. J. Immunol. 2002. 169: 7019-7025.
11. Nakayama, S., Du Clos, T. W., Gewurz, H. and Mold, C., Inhibition of antibody responses to phosphocholine by C-reactive protein. J. Immunol. 1984. 132: 1336-1340.
12. Du Clos, T. W., Zlock, L., Hicks, P. S. and Mold, C., Decreased autoantibody levels and enhanced survival of (NZB × NZW) F1 mice treated with C-reactive protein. Clin. Immunol. Immunopathol. 1994. 70: 22-27
13. Heuertz, R. M., Xia, D., Samols, D. and Webster, R. O., Inhibition of C5a des Arg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein. Am J. Physiol. 1994. 266: L649-654.
14. Hirschfield, G. K, Herbert, J., Kahan M. C. and Pepys, M. B., Human C-reactive protein does not protect against acute lipopolysaccharide challenge in mice. J. Immunol. 2003. 171: 6046-6051.
15. Mold, C., Nakayama, S., Holzer, T. J., Gewurz, H. and Du Clos, T. W., C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J. Exp. Med. 1981. 154: 1703-1708.
16. Xia, D. and Samols, D., Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc. Natl. Acad. Sci. USA 199Z 94: 2575-2580.
17. Gershov, D., Kim S., Brot, N. and Elkon, K. B., C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an and inflammatory innate immune response: implications for systemic autoinummity. J. Exp. Med. 2000.192: 1353-1364.
18. Du Clos, T. W. and Mold, C., C-reactive protein: An activator of innate immunity and a modulator of adaptive immunity. Immunol. Res. 2004. 30: 261-277.
19. Banchereau, J. and Steinman R. M., Dendrific cells and the control of immunity. Nature 1998. 392: 245-252.
20. Liu, Y. J., Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001. 106: 259-262.
21. Chapuis, F., Rosenzwajg, K, Yagello, M., Ekman, M., Biberfeld, P. and Gluckman, J. C., Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 199Z 27. 431-441.
22. + dendritic cells. Proc. Natl. Acad. Sci. USA 1996. 93: 2588-2592.
23. Rescigno, M., Winzler, C., Delia D., Mutini, C., Lutz, M. and Ricciardi-Castagnoli, P., Dendritic cell maturation is required for initiation of the immune response. J. Leukoc. Biol. 1997. 61: 415-421.
24. Labeur, M. S., Roters, B., Pers, B., Mehling A., Luger, T. A., Schwarz, T. and Grabbe, S., Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 1999. 162: 168-175.
25. Verma, S., Kuliszewski, M. A., Li, S. H., Szmitko, P. E., Zucco, L., Wang, C. H., Badiwala, M. V. et al., C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reacttve protein and cardiovascular disease. Circulation 2004. 109: 2058-2067.
26. Blaschke, F., Bruemmer, D., Yin, F., Takata, Y., Wang, W., Fishbein, M. C., Okura, T. et al., C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells. Circulation 2004. 110: 579-587.
27. Kew, R. R., Hyers, T. M. and Webster, R. O., Human C-reactive protein inhibits neutrophil chemotaxis in vitro: possible implications for the adult respiratory distress syndrome. J. Lab. Clin. Med. 1990. 115: 339-345.
28. Zahedi, K. and Mortensen, R. F., Macrophage turnoricidal activity induced by human C-reactive protein. Cancer Res. 1986. 46: 5077-5083.
29. Mortensen, R. F. and Duszkiewicz, J. A., Mediation of CRP-dependent phagocytosis through mouse macrophage Fc-receptors. J. Immunol. 1977. 119: 1611-1616.
30. Blutt, S. E., Crawford, S. E., Warfield, K. L., Lewis, D. E., Estes, M. K. and Conner, M. E., The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J. Virol. 2004. 78: 6974-6981.
31. van den Berg, C. W., Taylor, K. E. and Lang, D., C-reactive protein-induced in vitro vasorelaxation is an artifact caused by the presence of sodium azide in commercial preparations. Arterioscler. Thromb. Vasc. Biol. 2004. 24: el68-171.
32. van den Berg, C. W. and Taylor, K. E., Letter regarding article by Li et al., "C-reactive protein upregulates complement-inhibitory factors in endothelial cells". Circulation 2004. 110: e542.
33. Moser, M. and Murphy, K. M., Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 2000. 1: 199-205.
34. Steinman, R. M., DC-SIGN: a guide to some mysteries of dendritic cells. Cell 2000. 100: 491-494.
35. Torres, J. L. and Ridker, P. M., Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr. Opin. Cardiol. 2003. 18: 471-478.
36. Pepys, M. B., CRP or not CRP? That is the question. Arterloscler. Thromb. Vasc. Biol. 2005. 25: 1091-1094.
37. Taylor, K. F., Giddings, J. C. and van den Berg, C. W., C-reactive protein-induced in vitro endothelial cell activation is an artifact caused by azide and lipopolysaccharide. Arterioscler. Thromb. Vasc Biol, 2005. 25: 1225-1230.
38. Mortensen, R. F. and Zhong, W., Regulation of phagocytic leukocyte activities by C-reactive protein. J. Leukoc. Biol. 2000. 67. 495-500.
39. Mazer, S. P. and Rabbani, L. E., Evidence for C-reactive protein's role in (CRP) vascular disease: Atherothrombosis, immuno-regulation and CRP. J. Thromb. Thrombolysis 2004. 17. 95-105.
40. Stein, M. P., Mold, C. and Du Clos, T. W., C-reactive protein binding to murine leukocytes requires Fc gamma receptors. J. Immunol. 2000. 164: 1514-1520.
41. Fanger, M. W., Graziano, R. F., Shen, L. and Guyre, P. M., Fc gamma R in cytotoxicity exerted by mononuclear cells. Chem. Immunol. 1989. 47: 214-253.
42. Huizinga, T. W., van Kemenade, F., Koenderman, L., Dolman, K. M., von dem Borne, A. E., Tetteroo, P. A. and Roos, D., The 40-kDa Fc gamma receptor (FcRII) on human neutrophils is essential for the IgG-induced respiratory burst and IgG-induced phagocytosis. J. Immunol. 1989. 142: 2365-2369.
43. Anderson, C. L., Shen, L., Eicher, D. M., Wewers, X D. and Gill, J. K., Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes. J. Exp. Med. 1990. 171: 1333-1345.
44. Anegon, I., Cuturi M. C., Trinchieri, G. and Perussia, B., Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J. Exp. Med. 1988. 167: 452-472.
45. Bharadwaj, D., Stein, M. P., Volzer, M., Mold, C. and Du Clos, T. W., The major receptor for C-reactive protein on leukocytes is Fc gamma receptor II. J. Exp. Med 1999. 190: 585-590.
46. Marnell L. L., Mold, C., Volzer, M. A., Burlingame, R. W. and Du Clos, T. W., C-reactive protein binds to Fc gamma RI in transfected COS cells. J. Immunol. 1995. 155: 2185-2193.
47. Engering, A. J., Cella, M., Fluitsma, D., Brockhaus, M., Hoefsmit, E. C., Lanzavecchia, A. and Pieters, J., The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 1997. 27. 2417-2425.
48. Tan, M. C., Mommaas, A. M., Drijfhout, J. W., Jordens, R., Onderwater, J. J., Verwoerd, D., Mulder, A. A. et al., Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 1997 27. 2426-2435.
49. Stahl P., Schlesinger, P. H., Sigardson, E., Rodman, J. S. and Lee, Y. C., Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling. Cell 1980. 19: 207-215.
50. Jiang, W., Swiggard, W. J., Heufler, C., Peng, M., Mirza, A., Steinman, R. M. and Nussenzweig, M. C., The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995. 375: 151-155.
51. Black, S., Kushner, I. and Samols, D., C-reactive protein. J. Biol. Chem. 2004. 279: 48487-48490.
52. Klagge, I. M. and Schneider-Schaulies, S., Virus interactions with dendritic cells. J. Gen. Virol. 1999. 80 (Pt 4): 823-833.
53. Fujii, S., Liu, K., Smith, C., Bonito, A. J. and Steinman, R. M., The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/ 86 costimulation. J. Exp. Med. 2004. 199: 1607-1618.
54. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M. and Munz, C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002. 195: 343-351.